SCHEMBL8491325

SCHEMBL8491325

O=C(/C=C/c1ccccc1Oc1ccccc1)/C=C/c1ccccc1Oc1ccccc1

nearest known ligand 0.81

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTT P42858 1/20 0.81
▸ GAA P10253 2/20 0.65
▸ NFE2L2 Q16236 4/20 0.64
▸ TFEB P19484 1/20 0.64
▸ LMNA P02545 4/20 0.60
▸ KMT2A Q03164 1/20 0.59
▸ SMN1; SMN2 Q16637 2/20 0.59
▸ TLR4 O00206 1/20 0.57
▸ TLR2 O60603 1/20 0.57
▸ MAPT P10636 4/20 0.55
▸ NPC1 O15118 2/20 0.55
▸ RAB9A P51151 2/20 0.55
▸ KDM4E B2RXH2 2/20 0.55
▸ MAPK1 P28482 1/20 0.55
▸ ATM Q13315 1/20 0.55
▸ NPSR1 Q6W5P4 1/20 0.55
▸ TDP1 Q9NUW8 1/20 0.55
▸ ALDH1A1 P00352 2/20 0.54
▸ HPGD P15428 1/20 0.54
▸ LY96 Q9Y6Y9 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8491329 1.00 HTT (0.81) HTTGAANFE2L2TFEBLMNA
SCHEMBL1006523 0.89 HTT (1.00) HTTGAANFE2L2TFEBLMNA
SCHEMBL6714231 0.89 HTT (1.00) HTTGAANFE2L2TFEBLMNA
Hydrochloric Acid SCHEMBL11180824 0.88 HTT (0.97) HTTGAANFE2L2TFEBLMNA
SCHEMBL11180817 0.86 HTT (0.76) HTTGAANFE2L2TFEBLMNA
SCHEMBL9185939 0.86 HTT (0.76) HTTGAANFE2L2TFEBLMNA
SCHEMBL9185934 0.86 HTT (0.76) HTTGAANFE2L2TFEBLMNA
SCHEMBL30584121 0.86 HTT (0.76) HTTGAANFE2L2TFEBLMNA
SCHEMBL7770107 0.83 HTT (0.71) HTTGAANFE2L2TFEBLMNA
SCHEMBL15065737 0.83 HTT (0.71) HTTGAALMNAKMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0771196-B1 EXCITATORY AMINO ACID RECEPTOR ANTAGONISTS LILLY CO ELI (US) 1999-12-08 — — EP disclosed
US-5717109-A CARBOXYCYCLOPROPYL GLYCINE DERIVATIVES; USEFUL FOR TREATMENT OF ACUTE OR CHRONIC NEURODEGENERATIVE CONDITIONS, AND AS ANTIPSYCHOTIC, ANTICONVULSANT, ANALGESIC, ANXIOLYTIC, ANTIDEPRESSANT AND ANTI-EMETIC AGENTS ELI LILLY AND COMPANY (US) 1998-02-10 — — US disclosed
Send feedback